drugset

drugset / Trial / NCT02330276

Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin

NCT02330276 ↗

Phase 1 Completed 12 enrolled Veterans Medical Research Foundation National Center for Complementary and Integrative Health (NCCIH) · collab National Institutes of Health (NIH) · collab San Diego Veterans Healthcare System · collab University of California, San Diego · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Early Phase Pre-Clinical and Initial Clinical Research on (+)- Epicatechin.

Timeline

Start: 2014-09
Primary completion: 2015-08
Completion: 2015-08

Publications

Yao Q, Wei T, Qiu H, Cai Y, Yuan L, Liu X, Li X. Epigenetic Effects of Natural Products in Inflammatory Diseases: Recent Findings. Phytother Res. 2025 Jan;39(1):90-137. doi: 10.1002/ptr.8364. Epub 2024 Nov 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	(-)-Epicatechin	Unknown	10 mg	Oral
Subject	(-)-Epicatechin	Unknown	30 mg	Oral
Subject	(-)-Epicatechin	Unknown	100 mg	Oral

Indications